Brazil to receive China’s Sinovac COVID-19 vaccine, eyes Pfizer candidate
BRASILIA (Reuters) – Brazil’s Sao Paulo state is set to begin importing the first of 46 million doses of China’s Sinovac vaccine against COVID-19 this week, while the federal government takes a more cautious approach with a vaccine developed by Pfizer Inc.
Federal health officials met with Pfizer representatives on Tuesday as Brazil seeks to secure vaccine supplies. The Health Ministry said in a statement that it would buy the Pfizer vaccine, currently in Phase 3 trials, if it was proven safe and was registered with health authority Anvisa.
By Ricardo Brito and Anthony Boadle via Reuters